MedPath

Implementation and Assessment of a Life-style Focused Patient Support Application in Myocardial Infarction Patients

Not Applicable
Completed
Conditions
Myocardial Infarction
Interventions
Other: LifePod®
Registration Number
NCT03260582
Lead Sponsor
Lund University
Brief Summary

The study will assess the efficacy of a web-based application as a complement to traditional exercise-based cardiac rehabilitation for improvement of secondary prevention outcomes in post-myocardial infarction patients, compared with usual care. The hypothesis is that the intervention enhances patient adherence to lifestyle advice (exercise training, daily physical activity, healthy diet and tobacco abstinence) and medication, resulting in better risk factor control and prognosis as well as increased self-rated health.

Detailed Description

It is well documented that participation in cardiac rehabilitation (CR) programs improves risk factor control and therapy adherence, enhances quality of life and reduces recurrent events. However, the current incomplete fulfilment of guideline recommended CR targets is a matter of concern. Also, while international recommendations advocate program flexibility and individual tailoring, most of the current CR programs are rigid, time-limited and demand substantial health care resources. Therefore, all main international heart associations have claimed for the reengineering of CR to enhance access, adherence, and effectiveness. The general call is for the development of innovative and cost-effective CR programs oriented to modify lifestyle and behaviour with sustainable results and that may be easily integrated in the pre-existing health care structures.eHealth i.e. the use of electronic communication and information technologies in health care, offers a whole new array of possibilities to provide clinical care. These include for example distance monitoring via telecommunication and sensors, interactive computer programs and smart phone applications. While there are thousands of available eHealth applications on the market, only a small minority have been tested in a controlled manner with proper guidance from health care personnel. The study will assess the efficacy of a web-based patient support application as a complement to traditional exercise-based CR for improvement of secondary prevention outcomes in post-MI patients, compared with usual care. The hypothesis is that the intervention enhances patient adherence to lifestyle advice (exercise training, daily physical activity, healthy diet and tobacco abstinence) and medication, resulting in better risk factor control and prognosis as well as increased self-rated health. A secondary hypothesis is that complementing the application with an activity tracker (accelerometer in a smart bracelet) will enhance the effect of the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention arm: LifePod arm (n=100)LifePod®In addition to usual cardiac rehabilitation care, patients randomized to the LifePod arm will receive access to the LifePod® support software for six months.
Primary Outcome Measures
NameTimeMethod
Change in submaximal exercise capacity in watts (W)Change between first (2-4 weeks post-MI) and second (4-6 months post-MI) submaximal exercise test conducted at physiotherapist visits

Submaximal exercise capacity reflects the patients´ level of physical fitness.The submaximal exercise test is performed on a bicycle ergometer according to the World Health Organisation (WHO) protocol, with an increased workload of 25W every 4.5 minutes The initial starting load, 25W or 50W, is decided, based on the patient's exertion history. After two and four minutes of each workload; heart rate, rate of perceived exertion according to Borg's rating of perceived exertion scale (RPE) and subjective symptoms, including chest pain and dyspnea according to Borg's Category Ratio Scale, CR-10, scale are rated. After three minutes, the systolic blood pressure is registered. The exercise test is discontinued at Borg RPE 17 and/or dyspnea 7 on Borg's CR-10 scale.

Secondary Outcome Measures
NameTimeMethod
Change in BMIChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Weight in kilograms (kg) divided by height in meters (m) square

Change in waist circumferenceChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Waist circumference measured in cm

Change in systolic blood pressureChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Systolic blood pressure measured after 5 minutes of rest in supine position (mmHg)

Change in diastolic blood pressureChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Diastolic blood pressure measured after 5 minutes of rest in supine position (mmHg)

Change in total cholesterolChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Fasting plasma total cholesterol

Change in LDL cholesterolChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Fasting plasma LDL cholesterol (mmol/L)

Change in HDL cholesterolChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Fasting plasma HDL cholesterol (mmol/L)

Change in self-reported healthChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Self-reported Health is measured using the Visual Analogue Scale (0-100)

Change in healthy diet indexChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

The healthy diet index is a four-item questionnaire used to evaluate dietary habits within the Swedish Secondary Prevention after Heart Intensive Care Admission (SEPHIA) registry

Smoking habitsFirst (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Whether the patient is a non-smoker, prior smoker or current smoker (self-report)

Change in weightChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Weight measured in kg

Change in triglyceridesChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Fasting plasma triglycerides (mmol/L)

Change in fasting plasma glucoseChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Fasting plasma glucose (mg/dL)

Change in hemoglobin A1cChange between baseline, first (6-8 weeks post-MI) and second (12-14 months post-MI) nurse visits post-MI

Whole-blood hemoglobin A1c (mmol/mol) by International Federation of Clinical Chemistry (IFCC) standards

Changes in self-reported physical activityChange between baseline, first (2-4 weeks post-MI) and second (4-6 months post-MI) physiotherapist visits post-MI

Self-reported physical activity, as measured by Haskell and Frändin \& Grimby

UptakeSix months

The proportion of patients who log on to the patient interface at least once

AdherenceSix months

The proportion of patients registering data at least twice per week on a weekly basis throughout the intervention period

Number of contacts with the CR staff12-14 months

Number of telephone and physical contacts with the CR staff during the follow-up period

Incident cardiovascular events at one yearOne year

Incidence of cardiovascular events at one year after the index event: hospitalization for a new MI, heart failure or stroke and cardiovascular death

Incident cardiovascular events at three yearsThree years

Incidence of cardiovascular events at three years after the index event: hospitalization for a new MI, heart failure or stroke and cardiovascular death

Trial Locations

Locations (2)

Dept of Cardiology, Skane University Hospital

🇸🇪

Malmo, Sweden

Dept of Cardiology

🇸🇪

Umeå, Sweden

© Copyright 2025. All Rights Reserved by MedPath